MedPath

Testosterone

These highlights do not include all the information needed to use TESTOSTERONE GEL safely and effectively. See full prescribing information for TESTOSTERONE GEL. TESTOSTERONE gel for topical use CIIIInitial U.S. Approval: 1953

Approved
Approval ID

10dab294-6a43-4bb3-9d91-2d200c624ffb

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 7, 2023

Manufacturers
FDA

TWi Pharmaceuticals, Inc.

DUNS: 658402052

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Testosterone

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code24979-078
Application NumberANDA209390
Product Classification
M
Marketing Category
C73584
G
Generic Name
Testosterone
Product Specifications
Route of AdministrationTRANSDERMAL
Effective DateOctober 1, 2019
FDA Product Classification

INGREDIENTS (6)

testosteroneActive
Quantity: 16.2 mg in 1 g
Code: 3XMK78S47O
Classification: ACTIB
alcoholInactive
Code: 3K9958V90M
Classification: IACT
carbomer homopolymer type CInactive
Code: 4Q93RCW27E
Classification: IACT
isopropyl myristateInactive
Code: 0RE8K4LNJS
Classification: IACT
waterInactive
Code: 059QF0KO0R
Classification: IACT
sodium hydroxideInactive
Code: 55X04QC32I
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Testosterone - FDA Drug Approval Details